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ABSTRACT
The G2 to M phase transition in perch oocytes is regulated
by maturation promoting factor (MPF), a complex of Cdc2 and
cyclin B. In Anabas testudineus, a fresh water perch, 17a,20b-
dihydroxy-4-pregnen-3-one, the maturation inducing hormone
(MIH), induced complete germinal vesicle breakdown (GVBD)
of oocytes at 21 h. An unusual cyclin, p30 cyclin B, has been
identified in oocyte extract using both monoclonal and poly-
clonal antibodies. Surprisingly, Cdc2 could not be identified, al-
though a Northern blot with Cdc2 cDNA demonstrated expres-
sion of the gene. Purification of MPF through an immunoaffinity
column followed by SDS-PAGE showed three proteins, Cdc2, cy-
clin B, and a 20 kDa fragment, indicating earlier failure in im-
munodetection may be due to the interference by this fragment.
In uninduced oocytes, p30 cyclin B was present, and its expres-
sion was increased by MIH. MIH increased p30 cyclin B accu-
mulation at 3 h, a high level which was maintained between 9
and 21 h, but an effective increase in GVBD and H1 kinase
activation could only be observed between 15 and 21 h. This
delay in active MPF formation was found to be related to the
activation of Cdc25, phosphorylation of which was detected at
12 h, and a substantial increase occurred during 15–18 h. So-
dium orthovanadate, a tyrosine phosphatase inhibitor, inhibited
H1 kinase activity and GVBD, suggesting the requirement of
Cdc25 activity in MPF activation. Our results show occurrence
of pre-MPF in uninduced oocytes and its conversion to active
MPF requires dephosphorylation by Cdc25, the existence of
which has not yet been shown in fish.
meiosis, oocyte development
INTRODUCTION
Oocytes, once their full growth is attained, get arrested
at prophase of first meiosis. Maturation-inducing hormone
(MIH) relieves oocytes from this arrest. Progesterone has
been shown to function as MIH in frogs and higher verte-
brates, whereas in fish 17a,20b-dihydroxy-pregnen-3-one
(17a,20b-DP) is the MIH [1, 2]. MIH promotes the for-
mation of a dimeric protein kinase known as MPF [3, 4],
which in turn triggers meiotic maturation events like ger-
minal vesicle breakdown (GVBD) through dispersion of
nuclear lamina, chromosome condensation, and formation
of metaphase spindles [5–9]. Maturation-promoting factor
(MPF) is also shown to phosphorylate and activate EF1, an
eukaryotic polypeptide chain elongation factor, resulting in
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protein synthesis associated with oocyte maturation in fish
[10]. MPF has been purified from many vertebrates and
invertebrates, all of which share a strikingly common mo-
lecular structure [11]. This is a complex of two proteins, a
regulatory component called cyclin B and the catalytic
component protein kinase known as cyclin-dependent ki-
nase, Cdc2 [12–15]. Several investigators attempted to ex-
plain molecular mechanisms of MPF formation and acti-
vation during oocyte maturation in different species [16–
21] and found that despite the common molecular structure
of MPF in eukaryotes, mechanisms involved in active MPF
formation differ [22–27].
In the Xenopus model, even before MIH activity, pre-
formed cyclin B remains dimerized with Cdc2 to form pre-
MPF or inactive MPF. This complex is phosphorylated at
Thr161 but still remains inactive as the result of the inhib-
itory phosphorylation at Thr14 and Tyr15 [17, 28, 29]. Pro-
gesterone, the MIH in amphibians, stimulates Cdc25 to de-
phosphorylate Thr14 and Tyr15, which convert pre-MPF to
active MPF having only Thr161 phosphorylation [30, 31].
Injection of small amounts of MPF has been shown to auto-
amplify MPF through Cdc25-mediated dephosphorylation,
even in the presence of translation inhibitors [32, 33].
Cdc25 is inevitable for the progression of G2 to M phase
not only in Xenopus, but also in other vertebrates, including
mammals [34–38]. In contrast, pre-MPF is absent in im-
mature bovine and pig oocytes [39, 40]. Pre-MPF also does
not exist in fish [41–43]. Cell cycle is further controlled by
the subcellular localization effecting physical separation of
components [36, 37]. This model has been found valid for
most higher animals, including mammals [38, 39].
MPF has been purified and characterized from various
fish [41]. MIH induces de novo synthesis of cyclin B pro-
tein from its maternal mRNA, which in association with
Cdc2 form active MPF in fish [23, 42, 43]. According to
this model, preformed CDK1, a 34 kDa homologue of Sac-
charomyces pombe protein Cdc2, associates with newly
synthesized 46 kDa cyclin B protein to form MPF. MPF is
immediately phosphorylated at Thr161 of Cdc2 by cyclin-
dependent kinase activating kinase (CAK) resulting in its
activation [19]. Here, cyclin B translation, under MIH in-
duction, is the key factor regulating oocyte maturation.
There is no existence of Cdc25 because tyrosine phospha-
tase activity is not a requirement [41]. Mechanisms of MPF
activation in pig are similar to those in fish [40]. Cyclin B1
could not be detected in fully grown pig oocytes, and ac-
tivity of Cdc2 kinase is low. Following gonadotropin stim-
ulation, oocytes start to accumulate cyclin B1 with greater
Cdc2 kinase activity [44].
In this paper, we report the existence of pre-MPF in a
freshwater perch, Anabus testudineus, where a unique p30
cyclin B could be detected in uninduced oocytes and its
accumulation increased by MIH coinciding with histone H1
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kinase activity. Conversion of pre-MPF to MPF depends on
Cdc25 activation and a tyrosine phosphatase inhibitor that
blocks both Cdc25 activation and histone H1 phosphory-
lation. All of these indicate a different type of situation in
perch than what has so far been reported for fish.
MATERIALS AND METHODS
Animals and Oocytes
Climbing perch (A. testudineus, Bloch.) were collected from in and
around Santiniketan, West Bengal, India, during the prespawning and
spawning stages (mid-April to August) of the annual reproductive cycle
[45] and were maintained under controlled laboratory conditions until
used. Fish with gravid ovary were dissected to collect full-grown immature
ovarian follicles in ice-cold M199 medium (Sigma-Aldrich, St. Louis,
MO). These oocytes were manually defolliculated, denuded, and washed
several times with medium. Denudation effected GVBD or lysis in 5%–
7% of the oocytes. Healthy oocytes were selected after 1 h preincubation
prior to the addition of MIH. Denuded oocytes were subjected to MIH
induction in vitro by incubating oocytes at 308 6 28C in Medium199 with
0.6% salinity supplemented with penicillin (100 U/ml) and streptomycin
(100 mg/ml) with or without (control) 1 mg/ml 17a,20b-DP (Sigma-Al-
drich). Samples were collected in 3-h intervals up to the 21st hour of MIH
induction. One microgram per milligram cycloheximide (SRL, Mumbai,
India) or 1 mM sodium orthovanadate (Na3VO4; Sigma-Aldrich) was used
along with MIH in parallel incubations as negative control. Migration of
germinal vesicle (GV) and GVBD were determined by placing oocytes in
a clearing solution (ethanol, formaldehyde, acetic acid, 3:6:1; modified
from [46]) followed by microscopic examination. Viability of oocytes was
examined by trypan blue dye exclusion. Concentration of inhibitors (i.e.,
cycloheximide and Na3VO4) used for experiments were chosen after test-
ing for viability with trypan blue. All animal experiments were performed
in accordance with the guidance of the Animal Ethics Committee of the
Indian Institute of Chemical Biology.
Preparation of Oocyte Extracts
Fifty denuded oocytes were used per incubation. Oocytes were washed
with extraction buffer (EB) containing 100 mM sodium b-glycerophos-
phate, 20 mM HEPES, 15 mM MgCl2, 5 mM EGTA, 100 mM 4-amidi-
nophenylmethylsulfonyl fluoride, 3 mg/ml leupeptin, and 10 mg/ml apro-
tinin, pH 7.5 [47]. One microliter of EB/oocyte was added and homoge-
nized with a glass homogenizer. The homogenate was centrifuged at
17 500 3 g for 30 min at 48C and the supernatant was stored at 2208C
until further use.
Electrophoresis and Western Blot Analysis
Protein content in oocyte extract was determined according to the
method described by Lowry et al. [48] and run on a 12.5% SDS-PAGE
according to Laemmli [49]. Briefly, 10-ml samples were dissolved in 40
ml of 13 sample buffer containing 0.5 M Tris-HCl (pH 6.8), 10% glycerol,
2% SDS, 5% b-mercaptoethanol, and 0.1% bromophenol blue; heated for
3 min; cooled; and 10-ml aliquots loaded on the stacking gel (4%), which
was layered over a 12.5% running gel. Electrophoresis was carried out at
80 V constant voltage, and after completion of the run, the gel was either
stained with 0.1% Coomassie blue (overnight) for visualization or trans-
ferred to Immobilon P membrane (Millipore Corp., Bradford, MA) for
immunoblot. Membranes were incubated with 5% blocking buffer (Tris
buffered saline with 0.1% Tween 20 and 5% nonfat milk) for 1 h followed
by incubation with primary antibody overnight at 48C. Rat polyclonal anti–
cyclin B1 antibody; mouse monoclonal anti–cyclin B1 antibody (Santa
Cruz Biotechnology, Santa Cruz, CA); and goldfish anti–cyclin B mono-
clonal antibody (a kind gift from Dr. S. Haider, Banaras Hindu University,
India, who received it from Prof. Y. Nagahama, NIBB, Japan) were used
at 1:1000 dilution. Mouse anti-p34 Cdc2 monoclonal antibody and rabbit
anti-p34 Cdc2-PSTAIRE polyclonal antibody (Santa Cruz Biotechnology)
were used at 1:1000 dilution. Rabbit anti-phospho Cdc25C (Ser216) an-
tibody (Cell Signaling Technology, Beverly, MA) was used at 1:1000 di-
lution. Bound primary antibodies were visualized using corresponding sec-
ondary antibodies at 1:1000 dilution, which were tagged with either al-
kaline phosphatase or horseradish peroxidase and were developed with
corresponding substrates nitro blue tetrazolium/5-bromo 4-chloro 3-indoyl
phosphate or tetra methyl benzidine/H2O2 (SRL, Mumbai, India), respec-
tively.
H1 Kinase Activity
H1 kinase activity was measured according to Yamashita et al. [41].
Briefly, batches of 50 oocytes incubated with 1 mg/ml MIH containing
Medium199 at 308C for the indicated time intervals were homogenized in
50 ml EB using a glass homogenizer. The homogenate was centrifuged at
17 500 3 g, 48C for 30 min. Twenty microliters each of supernatants were
incubated at 308C for 2 min in the presence of the following: 100 mM
histone H1 (Type-III-S; Sigma-Aldrich); 500 mM ATP; 1.5 mCi g32P-ATP
(6000 Ci/mmol; Amersham Biosciences, Little Chalfont, UK); 1 mM
EGTA, 10 mM MgCl2; 4.5 mM 2-mercaptoethanol; and 20 mM Tris HCl
(pH 7.4). After terminating the reaction with 20 ml of 300 mM phosphoric
acid, 80 ml of reaction mixture was spotted on Whatman P81 phospho-
cellulose paper (Whatman, Brentford, UK), washed three times with 1%
phosphoric acid, and dried, and radioactivity was measured in a liquid
scintillation counter (LS 6000 SC, Beckman Coulter, Fullerton, CA).
To measure H1 kinase activity by autoradiography, the same procedure
was followed with the exception that kinase reaction was stopped by add-
ing 40 ml 13 SDS sample buffer, and 15 ml aliquots were analyzed on
15% SDS-PAGE, transferred to PVDF membrane, and autoradiographed
on Kodak Biomax MR film (Eastman Kodak Co., Rochester, NY).
Cloning of Cdc2 and Northern Analysis
Total RNA was extracted from full-grown denuded oocytes using Tri-
reagent (Sigma-Aldrich). Two micrograms of total RNA was reverse tran-
scribed with MuLV-reverse transcriptase (MBI Fermentas, Vilnius, Lith-
uania) primed with oligo (deoxythymidine; 59-GGAAGCTTTTTTTTTT
TTTTT-39). Reaction was carried out in 20 ml total volume containing 10
mM dithiotreitol (DTT), 0.5 mM of each deoxynucleotide triphosphate, 50
mM Tris-HCl (pH 8.3), 75 mM KCl, and 3 mM MgCl2 for 1 h at 428C.
Two microliters of first-strand cDNA was amplified in 50 ml PCR reaction
mixture containing 2.5 U Taq polymerase (Advantage2 RT-PCR kit, BD
Biosciences, Palo Alto, CA); 1.5 mM MgCl2; and 200 mM each of deoxy-
NTP (Sigma-Aldrich) and the buffer supplied with the enzyme along with
2 ml each of sense and antisense primers diluted to 10 mM. For designing
the primer, p34 Cdc2 kinase mRNA sequences from mouse (accession
U58633), frog (accession AF159158), and fish (accession D17758) were
aligned using ClustalW software (http://WWW.ch.embnet.org/ software/
clustalW.html). The following degenerate primers, 59-TA(T/C)GG(T/G)G
TGGTATATAAGGG-39 (sense) and 59-GCTGGTC(T/A)AT(T/C)TCTG
AGTC-39 (antisense), designed from consensus regions on multiple align-
ment, were used for amplifying an approximately 600 bp segment of perch
Cdc2 homologue. The PCR was performed for 30 cycles of denaturation
at 948C for 30 sec (5 min in the first cycle), annealing at 548C for 30 sec
and extension at 728C for 1 min (10 min last cycle; Perkin Elmer 9700;
PE Applied Biosystems, Foster City, CA) with a manual hot-start protocol.
PCR product was directly cloned into pTZ57R/T plasmid using InsT/A
clone PCR cloning kit (MBI Fermentas) following the manufacturer’s in-
structions. The cloned product was sequenced using ABI PRISM 3100
(Perkin Elmer; PE Applied Biosystems) automated sequencer. Sequence
analysis was done by BLAST software available on the NCBI web site
and submitted to the GenBank with the accession number AY533308. The
amino acid sequence derived from the perch Cdc2 cDNA matched a cor-
responding segment of Oryzias javanicus Cdc2 homologue accession num-
ber (accession BAB17220) over 99% (182/183). (See the supplementary
file for the details on primer designing, perch Cdc2 sequence, and multiple
alignment.)
Twenty micrograms of total RNA isolated from perch oocytes was
electrophoresed on 1% agarose-formaldehyde gel; transferred to a nylon
membrane (Hybond-N1, Amersham) by capillary suction method; and
cross-linked. A random labeled probe was prepared using an EcoRI di-
gested pTZ57R/T-Cdc2 insert and gel eluted using Quiaquick gel extrac-
tion kit (QIAGEN, Hilden, Germany). [a32P]d-ATP (Amersham) random
labeling was carried out with Hexa Label Plus DNA labeling system (MBI
Fermentas). Prehybridization was allowed for 2 h in the buffer containing
63 standard saline citrate (SSC) with 50% formamide, 13 Denhardt so-
lution, and 0.5% SDS at 428C. Hybridization was carried out under the
same conditions along with labeled Cdc2 cDNA for 18 h. The membrane
was washed for 30 min at 558C in 23 SSC and 0.1% SDS with three
repeats. The hybridized membrane was exposed to Kodak Biomax MR
film (Eastman Kodak).
Purification of MPF
Oocytes undergoing GVBD in vivo were collected and used as starting
material for purification of MPF. For this purpose, gravid perch were in-
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FIG. 1. MIH-induced maturation of perch
oocyte. A) Percentage GVBD (closed trian-
gles) of oocytes treated with MIH in-
creased sharply from 12 to 21 h. Untreat-
ed oocytes (closed circles) showed no
change. Cycloheximide (Chx) blocks MIH-
induced GVBD (open circles). All data are
mean 6 SEM of five independent observa-
tions. B) Left panel: SDS-PAGE of oocyte
extract from untreated (lane 1) and 18-h,
MIH-treated oocytes (lane 2) with low-
range molecular size markers in lane 3
(Amersham). Right panel demonstrates im-
munoblot of a denaturing gel with poly-
clonal anti–cyclin B antibody, which
cross-reacted with 30 kDa protein. This
protein showed a higher expression in re-
sponse to MIH. Note that this protein ex-
presses in uninduced oocytes as well. C)
Time-dependent increase of p30 cyclin B
in MIH-incubated oocytes was examined
by Western blot analysis using rat poly-
clonal anti-cyclin B antibody followed by
densitometric analysis (performed by using
a software Image Master 1D Elite from
Pharmacia Biotech). Perch oocyte extracts,
previously incubated with MIH for the in-
dicated time periods, were prepared in EB.
Fifty micrograms of protein were loaded in
each lane of a 12.5% SDS-PAGE and
transblotted to a PVDF membrane before
detection with rat polyclonal anti-cyclin B
antibody. Addition of Chx during incuba-
tion of oocytes prevented MIH-induced
accumulation of cyclin B detected by
mouse monoclonal anti-cyclin B antibody
(Inset). D) Histone H1 kinase activity of
MIH-incubated oocyte extracts; incuba-
tions were terminated at indicated time
points, and cytosolic extracts were subject-
ed to H1 kinase assay followed by SDS-
PAGE and autoradiography. Accompanying
photographs show migration of GV and
subsequent GVBD of oocytes of parallel
incubations coinciding with H1 kinase ac-
tivity (magnification 1003).
jected with carp gonadotropic hormone (purified by us [50]; 50 mg/fish)
intraperitoneally and oocytes were stripped out just before ovulation. Near-
ly all (97%–99%) of these oocytes exhibited GVBD. Approximately 105
oocytes were denuded and homogenized in EB and centrifuged at 17 500
3 g as mentioned above. The supernatant was subjected to ultracentrifu-
gation at 105 3 g in Beckman Ultracentrifuge for 1 h; supernatant was
applied to a DEAE-cellulose column (10 3 2 cm) equilibrated with EB
containing 15 mM NaCl. After washing the column, proteins were eluted
with discontinuous NaCl gradient of 50 and 100 mM in the same buffer.
Two milliliters of fractions were collected and subjected to histone H1
kinase determination.
The fractions containing histone H1 kinase activity were pooled; the
volume was reduced by lyophilization and chromatographed on a Sephad-
ex G-200 (Pharmacia Fine Chemicals, Uppsala, Sweden) column and
equilibrated with EB using a low-pressure Biologic LP chromatography
system (Biorad Laboratories Pvt. Ltd., Hercules, CA). Peak fractions were
pooled, lyophilized, dialyzed, and checked for H1 kinase activity.
Active peak was further purified by an immuno-affinity chromatogra-
phy using mouse anti–cyclin B1 monoclonal antibody linked to Sepharose
4B matrix (Amersham). Antibody was tagged to the matrix according to
the instructions from the manufacturer. SG 200 active peak was loaded
onto an affinity matrix and incubated overnight at 48C. The column was
washed with EB to remove unbound proteins. Bound protein(s) was eluted
with EB containing 2 M KI as chaotropic reagent, dialyzed, and lyophi-
lized to use in subsequent experiments.
Purified p13 Suc1 protein was a kind donation from Prof. Tim Hunt
(Cancer Research, UK, London, UK; Clare Hall Laboratories). The p13
Suc1 was conjugated to Cyanogen Bromide (CnBr) activated Sepharose
4B (Amersham) according to the instructions of the manufacturer. Un-
reacted groups of the gel were quenched with 1 M ethanolamine (pH 8.0).
The concentration of coupled Suc1 was approximately 3.5 mg/ml of gel.
A column (4 3 1 cm) was prepared with the matrix, and active peak from
S-200 was allowed to bind to the column overnight. The column was
washed consecutively with five column volumes of EB, 4M NaCl in EB,
and ultimately a 3 mM solution of Suc1 without NaCl [12] to elute the
unbound and bound proteins, respectively; optical density was measured
at 280 nm.
Microinjection of Oocytes
Affinity-eluted fractions from 6- or 18-h MIH-induced oocytes (6hAII
or 18hAII fraction, respectively) were pooled, dialyzed against water, and
concentrated by lyophilization, and approximately 7 pg protein was in-
jected into full-grown oocytes collected from control fish. With the help
of a local manufacturer, John Seal & Co. (Kolkata, India), we prepared
injection pipettes (outer diameter, 5 mm; inner diameter, 2 mm) and holding
pipettes (outer diameter, 18 mm; inner diameter, 15 mm). One hundred
oocytes were microinjected on an inverted phase-contrast microscope
(Olympus Optical Ltd., Tokyo, Japan) either with 6hAII or 18hAII fraction
or EB. About 15%–20% 18hAII injected oocytes underwent GVBD syn-
chronously when visualized with clearing solution after 1 h, whereas 6hAII
or EB (served as control) injected oocytes showed no GVBD.
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FIG. 2. Identification of Cdc2. A) Cdc2 could be detected in rat testis
extract by PSTAIRE antibody (lane 2), but could not be detected in perch
oocyte extract (lane 1). B) Northern hybridization of perch oocyte RNA
using perch Cdc2 cDNA (accession AY533308) detects mRNA of 1.5 kb
long, indicating Cdc2 gene expression.
FIG. 3. Purification of MPF from perch oocyte extract. A) Oocyte ex-
tracts were subjected to DEAE-cellulose chromatography. DEAE-bound
fractions eluted with 100 mM NaCl (closed circles) showed histone H1
kinase activity with 75 mg of protein (open circles). B) Further purification
of MPF on a Sephadex G200 column. The closed circle shows elution of
proteins in four major peaks of which SG-P3 fractions (10 mg protein)
demonstrated H1 kinase activity (crossed hair). C) SG-P3 was allowed to
bind overnight to the immuno-affinity matrix containing mouse monoclo-
nal anti-cyclin B antibody and Sepharose 4B. Column was washed with
extraction buffer to remove the unbound proteins (AI), and bound protein
was eluted with 2M KI (AII).
RESULTS
MIH-induced GVBD in perch oocytes increased sharply
from 12 h onward, which was blocked by cycloheximide
(Fig. 1A) indicating the requirement of new protein syn-
thesis. Extract of 18-h, MIH-incubated oocytes in SDS-
PAGE showed overexpression of 30 kDa protein (Fig. 1B,
left panel). Western blot analysis of control and MIH-in-
duced oocyte extracts showed cross-reaction of 30 kDa pro-
tein with rat polyclonal anti-cyclin B antibody, indicating
it to be a cyclin B. However, we confirmed this 30 kDa
protein as cyclin B by using mouse and goldfish anti-cyclin
B monoclonal antibodies. In perch, cyclin B could be de-
tected in uninduced oocytes, but its expression was in-
creased in response to MIH (Fig. 1B, right panel). The den-
sitometric analysis of Western blot shows an increased cy-
clin B content due to MIH from 3 to 12 h—which remained
almost in the same level during this period—and then a rise
between 15 and 21 h (Fig. 1C). The rise during 15 and 21
h appears to be critical as maximum GVBD occurred dur-
ing this period. The lag phase between 3 and 12 h in perch
oocyte maturation (Fig. 1A) was difficult to understand
since an MIH-induced increase in p30 cyclin B could be
detected during this period (Fig. 1C). Cycloheximide (Chx),
a translation inhibitor, blocked an MIH-induced increase of
cyclin B and also GVBD (Fig. 1, A and inset of C). De-
tection of cyclin B in uninduced oocytes of fish seems to
be unusual (Fig. 1, B and C), but that resembles the situ-
ation observed in Xenopus [17, 29, 51]. Although a higher
level of cyclin B was maintained between 3 and 12 h, it
did not coincide with histone H1 kinase activation or
GVBD. This suggests a critical requirement of cyclin B
content in oocytes to form an optimum mass of MPF, which
appears to be satisfied during 15–21 h of MIH induction as
both histone H1 phosphorylation and oocyte GVBD oc-
curred during this period (Fig. 1, A and D). However, we
failed to comprehend why a considerable level of cyclin B
between 3 and 12 h was unable to activate histone H1 ki-
nase or cause GVBD.
Surprisingly, Cdc2 could not be detected in perch oo-
cytes (Fig. 2A). A parallel experiment with rat testis extract
using PSTAIRE antibody in Western blot analysis clearly
identified Cdc2; this indicates that failure to detect Cdc2
with PSTAIRE antibody in perch oocyte extract is not the
result of experimental error. We have also used rabbit anti-
Cdc2 polyclonal antibody but could not detect Cdc2 (data
not shown). Presuming association of other proteins with
Cdc2, which may interfere with its immunodetection, p13
Suc1 a Sepharose column was used to isolate Cdc2. It was
intriguing to find all protein eluted without binding to the
matrix, and eluted material showed MPF activity, which
again did not exhibit Cdc2 in Western blot with anti-
PSTAIRE antibody (data not shown). We therefore attempt-
ed to observe Cdc2 gene expression in perch oocytes. An
RT-PCR with primers designed from the consensus se-
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FIG. 4. Identification of Cdc2 in the eluate from immunoaffinity column.
A) Immunoaffinity bound fraction, AII sample was specially treated by
using 5% SDS followed by boiling for 15 min and then subjected to 15%
SDS-PAGE. Gel was stained with silver showing three bands having 34,
30, and 20 kDa molecular sizes. Another similarly treated AII sample was
electrophoresed in 15% SDS-PAGE, and the gel was immunoblotted with
mouse monoclonal anti-cyclin B1 and anti-PSTAIRE antibodies. This time
34 kDa as Cdc2 could be identified by PSTAIRE antibody and 30 kDa as
cyclin B. B) AI and AII peaks were pooled separately and dialyzed, and
volume was reduced by lyophilization; 1.5 mg protein was added to the
incubation mixture to examine histone H1 kinase activity. C) Injection of
AII protein into the perch oocyte–effected GVBD. The representative fig-
ures on top were taken at 503 magnification.
FIG. 5. Final maturation of perch oocyte
closely follows Cdc25 phosphorylation
pattern. A) Extract from MIH-induced
perch oocyte at different time levels was
immunoblotted by using rabbit anti-
pCdc25C antibody. B) MIH-induced
GVBD was blocked by tyrosine phospha-
tase inhibitor, Na3VO4. C) Histone H1 ki-
nase activity of oocyte extract induced by
MIH is also ablated by Cdc25C inactiva-
tion.
quence of Cdc2 of different animals including goldfish gave
a product, which showed homology to known fish Cdc2
sequences, and was cloned. Cdc2 cDNA hybridized with
perch oocyte total RNA (Fig. 2B), transcript size (;1.6 kb),
was close to the known Cdc2 genes as evident from
GenBank.
To understand why Cdc2 protein could not be detected
in immunoblots using anti-Cdc2 or anti-PSTAIRE antibod-
ies, we partially purified MPF by using a DEAE cellulose
column (Fig. 3A) and SG200 gel chromatography (Fig.
3B). We then prepared an immunoaffinity column with anti-
cyclin B1-Sepharose 4B matrix to isolate MPF. Anti-cyclin
B antibody bound material was eluted in AII fractions (Fig.
3C). AII fraction resolved into three bands in SDS-PAGE
of molecular masses 34, 30, and 20 kDa (Fig. 4A). The 34
kDa protein clearly cross-reacted with anti-PSTAIRE anti-
body, thus showing it as Cdc2. The 30 kDa protein cross-
reacted with mouse monoclonal anti-cyclin B antibody,
whereas the 20 kDa fragment appears to be a contamination
that probably masked immunodetection of Cdc2. Immu-
noaffinity eluate, AII, showed strong H1 kinase activity
(Fig. 4B). Injection of 18hAII caused GVBD, whereas
6hAII had no effect (Fig. 4C). This shows the difference
between pre-MPF and MPF activity. Oocytes injected with
EB did not produce any effect (photograph not shown).
Although cyclin B and Cdc2 were present in uninduced
oocyte, why MPF remained inactive until 15 h after MIH
treatment required an answer. During this period, pre-MPF
possibly started to convert to active MPF and reached the
peak at 18–21 h. This indicates the appearance of a factor
at about 15 h. We suspected this to be Cdc25. Therefore,
we used specific phospho-antibody against Cdc25C to mon-
itor its phosphorylation at different time intervals. Figure
5A shows that activation of Cdc25 could be detected from
12 h onward, which intensified at 18 h. Involvement of
Cdc25 in perch oocyte maturation was further substantiated
by the observations that sodium orthovanadate (Na3VO4),
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an inhibitor of tyrosine phosphatase activity, blocked MIH-
induced GVBD (Fig. 5B) and histone H1 phosphorylation
(Fig. 5C). These experiments clearly show the importance
of activation of Cdc25 in the final maturation of perch oo-
cytes.
DISCUSSION
In this paper we report that in A. testudineus, a fresh-
water perch, cyclin B exists in uninduced oocytes, which
is a deviation from what has so far been reported in fish.
Cyclin B is de novo synthesized in fish oocyte from ma-
ternal mRNA by MIH induction, and by associating with
Cdc2 it forms active MPF [23, 24, 31–33]. In contrast, MIH
induces greater accumulation of cyclin B in perch oocytes.
This 30 kDa protein cross-reacted with both monoclonal
and polyclonal cyclin B antibodies from goldfish, mouse,
and rat. Because cycloheximide blocks MPF activity, there
may be an optimum requirement of MIH-induced, newly
synthesized cyclin B that on association with Cdc2 forms
a critical mass of MPF to achieve the peak of GVBD during
15–21 h. Perch oocytes have an unusual cyclin B in terms
of molecular mass (i.e., 30 kDa, which is much smaller than
the 46–55 kDa cyclin B reported in other animals [52–54]).
This immunoreactive cyclin B as a constituent of MPF is
reflected from its overexpression by MIH at 18 h when
GVBD is in peak; its inhibition by cycloheximide at 18 h
then coincides with inhibition of GVBD. Immunoaffinity
eluate through anti-cyclin B matrix, containing p30 cyclin
B and p34 Cdc2, showed strong MPF activity both in terms
of H1 kinase activity and GVBD. Moreover, injection of
immunoaffinity eluate to uninduced perch oocyte caused
GVBD. MIH activity in perch oocyte followed by MPF
activation has similarity with the Xenopus model. In Xen-
opus, preformed cyclin B remains dimerized with Cdc2 to
form pre-MPF, and MIH induces new synthesis of cyclin B
for Cdc2 kinase activation [51].
We are confronted with two aspects in our findings: 1)
why we could not detect Cdc2 in perch oocyte and 2) why
the presence of appreciable amounts of cyclin B during 6–
12 h in response to MIH could not augment H1 kinase
activity and GVBD. To address the first aspect, we attempt-
ed purification of perch oocyte MPF presuming that Cdc2
may partially remain blocked with contaminating protein,
which probably disallowed cross-reaction with PSTAIRE
antibody or Cdc2 polyclonal antibody. To detect Cdc2, we
prepared an anti-cyclin B antibody-Sepharose 4B matrix
(using mouse monoclonal anti-cyclin B) so that Cdc2 could
be co-eluted with anti-cyclin B bound protein. To get the
separation of Cdc2 in SDS-PAGE, we had to use 15% gel
and 10 min boiling with sample buffer, and this treatment
attributed Cdc2 separation and then identification by the
PSTAIRE antibody. SDS-PAGE of immunoaffinity eluate
showed three protein bands: 34, 30, and 20 kDa. The 34
kDa protein was identified as Cdc2, and 30 kDa as cyclin
B. Association of p20 with the cyclin B–Cdc2 complex
probably interferes with Cdc2 immunodetection. MPF as-
sociation with p20 opens new possibilities. A regulatory
protein RINGO has recently been shown to be associated
with Cdc2 in Xenopus oocyte [55]. The p20 is smaller than
RINGO [22], and its regulatory role is not known. How-
ever, future investigation with p20 is indeed very necessary.
The second aspect, where accumulation of appreciable
amounts of cyclin B induced by MIH from 3–12 h did not
show stimulation of H1 kinase activity or GVBD, suggests
an increase in pre-MPF during this span of time. This is a
situation very similar to the mechanisms involved in Xen-
opus oocyte maturation [29]. There, Cdc2 and cyclin B re-
main dimerized as pre-MPF; phosphorylation of Thr161
could not activate MPF because of Thr14 and Tyr15 phos-
phorylation, which inhibits MPF activity [17, 41, 42]. Ac-
tivation of pre-MPF requires inhibition of wee 1 protein
kinase that phosphorylates Tyr15 of p34 Cdc2, as well as
activation of Cdc25, a phosphatase that removes this inhib-
itory phosphate [56]. The lag phase until 12 h of MIH
induction and a sharp rise of MPF activity from 12 h on-
ward indicates the appearance of a factor that can rapidly
convert pre-MPF to active MPF. We thought that a suitable
candidate for such rapid conversion is Cdc25 because in-
hibitory phospho-Tyr15 is already remaining with the in-
active MPF; hence wee 1 is not a candidate. With this idea
in mind, we have used specific anti-phospho-Cdc25C,
which is activated by phosphorylation at Ser216 residue.
Detection of phosphorylated Cdc25 at 12 h and its increase
at 15–18 h showed that MPF activation in perch oocytes
requires Cdc25 phosphatase activity. The pattern of Cdc25
activation coincides with the H1 kinase phosphorylation
and GVBD. Requirement of Cdc25 in MPF activation in
perch oocyte is further supported from the experiment
where sodium orthovanadate, a tyrosine phosphatase inhib-
itor, inhibited histone H1 kinase activation and GVBD.
Reports on the mechanisms of oocyte maturation in tel-
eosts show that phosphorylation of Thr161 residue on Cdc2
(after it binds to cyclin B) by CAK results in the activation
of MPF [19, 43] and does not include phosphorylation and
subsequent dephosphorylation on Tyr15. Contrary to these
reports, MPF activation in perch requires Cdc25 phosphor-
ylation, indicating existence of a different pathway in this
teleost. How Cdc25 is activated in A. testudineus is yet to
be investigated, but the presence of this phosphatase in a
fish and its relationship with MPF in regulating final mat-
uration is new information. Further investigation with perch
oocytes would be interesting and may provide meaningful
insight in terms of the evolution of regulatory mechanisms
involved in oocyte maturation.
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